Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435723 | 0.87 | CTSL (0.45) | CTSLCTSSCTSKPIK3R1PIK3CA | |
| SCHEMBL4328219 | 0.81 | CTSL (0.46) | CTSLCTSSCTSKPIK3R1PIK3CA | |
| SCHEMBL5716618 | 0.78 | CTSL (0.44) | CTSLCTSSCTSKTRPV3ALDH1A1 | |
| SCHEMBL29384418 | 0.76 | — | — | |
| SCHEMBL361070 | 0.76 | — | — | |
| SCHEMBL31435768 | 0.76 | ALDH1A1 (0.44) | PIK3R1PIK3CAALDH1A1MAPK1CES2 | |
| SCHEMBL22675250 | 0.74 | ALDH1A1 (0.39) | PIK3CAALDH1A1MAPK1PDE3BPDE3A | |
| SCHEMBL21755999 | 0.74 | CXCR2 (0.44) | ALDH1A1PDK2 | |
| SCHEMBL577838 | 0.73 | KDM1A (0.41) | CES2CES1 | |
| SCHEMBL29544666 | 0.73 | KDM1A (0.41) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078149-A1 | 6-(2-Halophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | disclosed |
| EP-1697367-A1 | 6-(2-HALOPHENYL)-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION AND THEIR USE FOR COMBATING PATHOGENIC FUNGI, IN ADDITION TO AGENTS CONTAINING SAID SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005058907-A1 | 6-(2-HALOPHENYL)-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION AND THEIR USE FOR COMBATING PATHOGENIC FUNGI, IN ADDITION TO AGENTS CONTAINING SAID SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078149-A1 | 6-(2-Halophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | CBR1, CBR3, HDHD5 | CTSL 2244/4885CTSS 3573/4885CTSK 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.